Clinical Trials

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07537738 2026-04-17

MLL-LSC

210 enrolled

Phase 1/2 Active not recruiting

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT00466531 2026-04-16

Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

50 enrolled

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00816114 2026-04-16

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

3,000 enrolled

Phase 2 Active not recruiting

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02131584 2026-04-16

Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

10 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

80 enrolled

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

NCT04140487 2026-04-16

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Phase 1/2 Recruiting

97 enrolled

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases

NCT04493138 2026-04-16

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

Phase 1/2 Recruiting

58 enrolled

Phase 2 Active not recruiting

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic

NCT04552288 2026-04-16

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

51 enrolled 8 charts

Hematologic Neoplasms

NCT04592250 2026-04-16

Financial Toxicity in Cancer Patients

Active not recruiting

625 enrolled

Hematologic Neoplasms

NCT04641910 2026-04-16

FLAMVAL

Completed

201 enrolled

Leukemia, Myeloid, Acute

NCT04829539 2026-04-16

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Phase 3 Recruiting

400 enrolled

Hematologic Neoplasms

NCT04888338 2026-04-16

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

100 enrolled

Hematologic Neoplasms

NCT05012124 2026-04-16

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

Phase NA Terminated

297 enrolled

Phase NA Active not recruiting

Depression, Hematologic Neoplasms

NCT05075759 2026-04-16

SALSA

374 enrolled

Hematologic Neoplasms

NCT05101213 2026-04-16

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Phase 1 Recruiting

30 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Hematologic Neoplasms

NCT05417971 2026-04-16

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

20 enrolled

Phase 2 Active not recruiting

Hematologic Neoplasms

NCT05456698 2026-04-16

Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy

31 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05537896 2026-04-16

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

55 enrolled

Neutropenia, Hematologic Neoplasms

NCT06074666 2026-04-16

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Phase NA Recruiting

100 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06439199 2026-04-16

CYTOK-AZA

60 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06458244 2026-04-16

The Efficacy of Allo-HSCT in ND HR-CBF-AML

90 enrolled

Leukemia, Myeloid, Acute

NCT06510699 2026-04-16

PRAGMATIC

104 enrolled

Communicable Diseases, Infections, Mycoses, Neoplasms, Hematologic Neoplasms

NCT06782542 2026-04-16

OLUVENAZA

16 enrolled

Leukemia, Myeloid, Acute

NCT06817720 2026-04-16

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

50 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06870760 2026-04-16

Pre-malignant States to Hematologic Malignancies in Firefighters

LymphoidOther hematologic neoplasmPlasma cell

300 enrolled

Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Paraproteinemias, Neoplasms, Plasma Cell

NCT07224100 2026-04-16

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

33 enrolled

Phase NA Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07454226 2026-04-16

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

30 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07493538 2026-04-16

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

132 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07519811 2026-04-16

oncOPAL

Phase NA Recruiting

150 enrolled

Phase 1 Not yet recruiting

Hematologic Neoplasms

NCT07532746 2026-04-16

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

55 enrolled